ALDX Archived Articles
Aldeyra Therapeutics, Inc. (ALDX): Pioneering RASP-Modulating Therapeutics for Immune-Mediated and Metabolic Diseases
Published on November 30, 2024
Aldeyra Therapeutics, Inc. (NASDAQ:ALDX): A Promising Biotech Poised for Growth
Published on September 24, 2024